🔎 Trials Near Me

Inicio › Sobrepeso › Texas › San Antonio

Ensayos clínicos de Sobrepeso en San Antonio, TX

33 estudios para Sobrepeso buscan participantes en centros de San Antonio y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.

Texto oficial del estudio (inglés)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

ReclutandoFase 3
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research, San Antonio
  • y 1 más
Edades de 8 a 18 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07253285

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

ReclutandoFase 3
  • VIP Trials, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07595549

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

ReclutandoFase 3
  • Sleep Therapy Research Center, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

ReclutandoFase 3
  • IMA Clinical Research San Antonio, San Antonio
  • VIP Trials, San Antonio, TX 78230
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07794579

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

ReclutandoFase 1
  • Endeavor Clinical Trials, San Antonio
Edades de 18 a 65 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07399678

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

ReclutandoFase 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ReclutandoFase 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

ReclutandoFase 3
  • IMA Clinical Research San Antonio, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

ReclutandoFase 3
  • Bandera Family Health Care, San Antonio
  • Consano Clinical Research - Shavano Park, Shavano Park · A 12 mi de distancia
Edades de 45 a 99 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

ReclutandoFase 3
  • VIP Trials, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

ReclutandoFase 3
  • IMA Clinical Research San Antonio, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

ReclutandoFase 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07784270

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • Endeavor Clinical Trials, San Antonio
Edades de 18 a 75 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

ReclutandoFase 3
  • IMA Clinical Research San Antonio, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

ReclutandoFase 3
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07369011

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ReclutandoFase 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

ReclutandoFase 3
  • AURORA-1 Clinical Site, San Antonio
  • AURORA-1 Clinical Site, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

ReclutandoFase 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

ReclutandoFase 3
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • IMA Clinical Research - San Antonio, San Antonio
  • Consano Clinical Research, Shavano Park · A 12 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07351045

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

ReclutandoFase 2
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 sept 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ReclutandoFase 3Se aceptan voluntarios sanos
  • ACCOMPLISH-2 Research Site, San Antonio
  • ACCOMPLISH-2 Research Site, San Antonio
Edades de 18 a 79 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ReclutandoFase 3
  • Sleep Therapy Research Center, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ReclutandoFase 3
  • Sleep Therapy Research Center, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07571109

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

ReclutandoFase 2
  • Consano Clinical Research, LLC, Shavano Park · A 12 mi de distancia
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • Endeavor Clinical Trials, San Antonio
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06143956

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

ReclutandoFase 1Se aceptan voluntarios sanos
  • ICON, San Antonio
Edades de 18 a 55 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07767175

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

ReclutandoFase 3
  • Clinical Trials of Texas, San Antonio
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684235

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

ReclutandoFase 1Se aceptan voluntarios sanos
  • ICON Early Phase Services, LLC, San Antonio
Edades de 18 a 65 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

ReclutandoFase 3
  • Research Site, San Antonio
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT07784725

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

ReclutandoFase 1Se aceptan voluntarios sanos
  • ICON Early Phase Services, San Antonio
Edades de 18 a 65 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07738614

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ReclutandoFase 3
  • ACCOMPLISH-1 Research Site, San Antonio
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361

Ensayos de Sobrepeso en otras ciudades

Otros estudios en San Antonio

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.